Walgreens Boots Alliance Inc (NASDAQ:WBA) Expected to Announce Quarterly Sales of $34.23 Billion
Equities analysts expect that Walgreens Boots Alliance Inc (NASDAQ:WBA) will report sales of $34.23 billion for the current fiscal quarter, Zacks reports. Six analysts have made estimates for Walgreens Boots Alliance’s earnings, with the lowest sales estimate coming in at $32.19 billion and the highest estimate coming in at $35.97 billion. Walgreens Boots Alliance reported sales of $34.59 billion during the same quarter last year, which would suggest a negative year over year growth rate of 1%. The firm is scheduled to report its next earnings results on Thursday, June 25th.
According to Zacks, analysts expect that Walgreens Boots Alliance will report full year sales of $138.47 billion for the current year, with estimates ranging from $134.92 billion to $141.49 billion. For the next fiscal year, analysts expect that the firm will report sales of $143.18 billion, with estimates ranging from $140.30 billion to $149.17 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that that provide coverage for Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.06. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company had revenue of $35.82 billion for the quarter, compared to analysts’ expectations of $35.24 billion. During the same quarter in the prior year, the business posted $1.64 EPS. The business’s revenue was up 3.7% compared to the same quarter last year.
Shares of Walgreens Boots Alliance stock traded down $0.15 on Tuesday, reaching $39.60. 3,391,244 shares of the company were exchanged, compared to its average volume of 7,383,946. Walgreens Boots Alliance has a one year low of $36.65 and a one year high of $64.50. The company has a market capitalization of $34.74 billion, a price-to-earnings ratio of 10.15, a PEG ratio of 1.83 and a beta of 0.55. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 1.34. The company has a 50-day moving average of $42.22 and a 200 day moving average of $51.33.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Wednesday, May 20th will be given a dividend of $0.4575 per share. The ex-dividend date of this dividend is Tuesday, May 19th. This represents a $1.83 annualized dividend and a dividend yield of 4.62%. Walgreens Boots Alliance’s dividend payout ratio is currently 30.55%.
Hedge funds have recently made changes to their positions in the stock. Norges Bank bought a new position in Walgreens Boots Alliance in the fourth quarter valued at about $492,928,000. American International Group Inc. raised its position in Walgreens Boots Alliance by 781.9% in the fourth quarter. American International Group Inc. now owns 5,511,875 shares of the pharmacy operator’s stock valued at $324,980,000 after purchasing an additional 4,886,896 shares during the last quarter. Aristotle Capital Management LLC raised its position in Walgreens Boots Alliance by 53.2% in the first quarter. Aristotle Capital Management LLC now owns 7,289,353 shares of the pharmacy operator’s stock valued at $333,488,000 after purchasing an additional 2,529,868 shares during the last quarter. APG Asset Management N.V. raised its position in Walgreens Boots Alliance by 105.4% in the first quarter. APG Asset Management N.V. now owns 4,695,281 shares of the pharmacy operator’s stock valued at $264,568,000 after purchasing an additional 2,409,392 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in Walgreens Boots Alliance by 17.6% in the first quarter. JPMorgan Chase & Co. now owns 9,039,778 shares of the pharmacy operator’s stock valued at $413,569,000 after purchasing an additional 1,350,716 shares during the last quarter. Institutional investors and hedge funds own 58.03% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.